Low-dose Carbon Monoxide (HBI-002) Trial to Evaluate Safety, Tolerability, PK, and Biomarkers in Parkinson's Disease

Clinical trial NCT07005180 · RECRUITING

Trial details

NCT number: NCT07005180
Sponsor: Hillhurst Biopharmaceuticals, Inc.
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Parkinson Disease

Start date: 2026-06-30
Primary completion: 2026-12-31
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.